Please use this identifier to cite or link to this item:
Title: Polymeric nanoparticle formulation of Octapeptide (NP-OP): In vitro release and in vivo effect in common marmosets, Callithrix jacchus Linn.
Authors: Nandedkar, TD
Sagvekar, P
Thakur, B
Navlakhe, R
Chitnis, S
Mahale, SD
D’Souza, S
Patel, KD
Vavia, PR
Keywords: Anti-fertility;Encapsulation efficiency;Follicle stimulating hormone binding-inhibitor;Polylactide;Synthetic peptides;TEM
Issue Date: Dec-2013
Publisher: NISCAIR-CSIR, India
Abstract: Octapeptide (OP)/FSH-Receptor Binding Inhibitor-8 (FRBI-8), is a synthetic peptide corresponding to N-terminal sequence of purified fraction of Follicle Stimulating Hormone Binding-Inhibitor (FSHBI), isolated earlier from human ovarian follicular-fluid. In order to avoid the repeated drug-administration, OP-loaded, polymeric polylactide (PLA) nanoparticle formulation (NP-OP), was developed using multiple-emulsion technique. This yielded an average particle size of 120 nm with 70% encapsulation-efficiency. In vitro release profile of NP-OP showed sustained release of OP for 21 days. In vivo anti-fertility studies were conducted in marmosets. Results indicated that control animals conceived in the same cycle while two of three treated animals failed to conceive in treatment cycle. The in vivo studies thus corroborate with in vitro release of OP, demonstrating its anti-fertility activity in 66% of animals.
Page(s): 1055-1062
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.51(12) [December 2013]

Files in This Item:
File Description SizeFormat 
IJEB 51(12) 1055-1062.pdf277.96 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.